Bay Colony Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-80,000
Closed -$2.22M 411
2023
Q4
$2.22M Hold
80,000
0.44% 53
2023
Q3
$2.24M Hold
80,000
0.54% 43
2023
Q2
$2.5M Hold
80,000
0.6% 39
2023
Q1
$2.23M Hold
80,000
0.59% 36
2022
Q4
$2.09M Buy
80,000
+35,000
+78% +$837K 0.55% 42
2022
Q3
$1M Hold
45,000
0.3% 84
2022
Q2
$1.15M Hold
45,000
0.29% 86
2022
Q1
$1.18M Hold
45,000
0.28% 89
2021
Q4
$1.05M Hold
45,000
0.3% 91
2021
Q3
$1.39M Hold
45,000
0.45% 65
2021
Q2
$1.1M Hold
45,000
0.37% 84
2021
Q1
$841K Hold
45,000
0.32% 92
2020
Q4
$898K Buy
45,000
+20,000
+80% +$366K 0.48% 65
2020
Q3
$414K Buy
+25,000
New +$454K 0.26% 120

Other funds holding ALKS

Bay Colony Advisors's ALKS Position: Q1 2024 in Review

Bay Colony Advisors sold out of Alkermes (ALKS) in Q1 2024, closing a stake of 80,000 shares — an estimated $2.22M sold.

Bay Colony Advisors first reported a position in ALKS in Q3 2020 and held it in 14 quarters. The position peaked at $2.5M in Q2 2023. 336 funds tracked by Wall St. Rank hold ALKS as of Q1 2024.

  • Bay Colony Advisors reported no remaining Alkermes position as of Q1 2024 after selling out during the quarter.
  • Bay Colony Advisors sold 80,000 Alkermes shares in Q1 2024, an estimated $2.22M.
  • Bay Colony Advisors first reported a position in Alkermes in Q3 2020 and held it in 14 quarters.
  • Bay Colony Advisors's Alkermes position peaked at $2.5M in Q2 2023.
  • 336 funds tracked by Wall St. Rank held Alkermes as of Q1 2024.

Based on Bay Colony Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.